Unregistered Sales of Equity Securities and Use of Proceeds
−Removed: There were no sales of equity securities during the thirteen weeks ended September 24, 2023 that were not registered under the Securities Act.
−Removed: Share Repurchases - The following table provides information regarding our purchases of common stock during the thirteen weeks ended September 24, 2023:
+Added: In connection with the 2025 Notes Partial Repurchase, which is described in further detail within Note 9 - Convertible Senior Notes of the Notes to the Consolidated Financial Statements, the Company delivered to the Noteholders an aggregate amount of 7,489,712 shares of common stock and $3.3 million in cash, including accrued interest, in exchange for $83.6 million in aggregate principal amount of the Company’s outstanding 2025 Notes.
+Added: The 2025 Notes Partial Repurchase transaction closed on March 5, 2024.
+Added: During the thirteen weeks ended March 31, 2024, certain holders of our 2025 Notes elected to convert $0.5 million in aggregate principal amount of 2025 Notes for a combination of $0.5 million in cash and 26,031 shares of common stock.
+Added: In connection with this conversion, we exercised our rights under certain convertible note hedge transactions and received a proportionate amount of our common stock during the thirteen weeks ended March 31, 2024.
+Added: The Company’s shares of common stock issued in connection with the 2025 Notes Partial Repurchase were not registered under the Securities Act, and were issued in reliance on exemptions from the registration requirements thereof provided by Section 4(a)(2) of the Securities Act in transactions by an issuer not involving a public offering.
+Added: The Company’s shares of common stock issued in connection with the 2025 Notes conversion were not registered under the Securities Act, and were issued in reliance on exemptions from the registration requirements thereof provided by Sections 4(a)(2) and 3(a)(9) of the Securities Act.
+Added: There were no other sales of equity securities during the thirteen weeks ended March 31, 2024 that were not registered under the Securities Act.
+Added: Share Repurchases - The following table provides information regarding our purchases of common stock during the thirteen weeks ended March 31, 2024:
REPORTING PERIOD TOTAL NUMBER OF SHARES PURCHASED AVERAGE PRICE PAID PER SHARE TOTAL NUMBER OF SHARES PURCHASED AS PART OF PUBLICLY ANNOUNCED PLANS OR PROGRAMS APPROXIMATE DOLLAR VALUE OF SHARES THAT MAY YET BE PURCHASED UNDER THE PLANS OR PROGRAMS (1)
−Removed: June 26, 2023 through July 23, 2023 209,996 $ 27.02 209,996 $ 98,143,201
−Removed: July 24, 2023 through August 20, 2023 95,577 $ 27.23 95,577 $ 95,540,716
−Removed: August 21, 2023 through September 24, 2023 284,763 $ 26.97 284,763 $ 87,861,050
+Added: January 1, 2024 through January 28, 2024 272,594 $ 26.08 272,594 $ 62,890,980
+Added: January 29, 2024 through February 25, 2024 199,967 $ 26.96 199,967 $ 57,500,724
+Added: February 26, 2024 through March 31, 2024 6,475,350 $ 27.18 6,475,350 $ 130,000,000
Total 6,947,911 6,947,911
____________________
−Removed: (1) On February 7, 2023, our Board approved a share repurchase authorization of up to $125.0 million of our outstanding common stock as announced in our press release issued February 16, 2023 (the “2023 Share Repurchase Program”).
+Added: (1) In February 2024, our Board cancelled the remaining $57.5 million under the former share repurchase authorization and approved a new share repurchase authorization of up to $350.0 million of our outstanding common stock as announced in our press release issued February 23, 2024 (the “2024 Share Repurchase Program”).
The 2024 Share Repurchase Program will expire on August 13,
+Added: BLOOMIN’ BRANDS, INC.
+Added: The remaining share repurchase authorization under the 2024 Share Repurchase Program as of March 31, 2024 gives effect to the full $220.0 million amount of our March 2024 accelerated share repurchase agreement, notwithstanding that final settlement occurred on April 23, 2024.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.